183 related articles for article (PubMed ID: 34143773)
1. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
[TBL] [Abstract][Full Text] [Related]
3. Myeloid Lineage Ablation of
Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
[TBL] [Abstract][Full Text] [Related]
4. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
[TBL] [Abstract][Full Text] [Related]
5. Ovariectomy-induced bone loss in
Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C
J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399
[TBL] [Abstract][Full Text] [Related]
6. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
[TBL] [Abstract][Full Text] [Related]
7. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
8. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
[TBL] [Abstract][Full Text] [Related]
9. Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.
Kim JL; Kim YH; Kang MK; Gong JH; Han SJ; Kang YH
Biomed Res Int; 2013; 2013():919374. PubMed ID: 23781510
[TBL] [Abstract][Full Text] [Related]
10. ST2 regulates bone loss in a site-dependent and estrogen-dependent manner.
Macari S; Madeira MFM; Lima ILA; Pereira TSF; Dias GJ; Cirelli JA; de Molon RS; Fukada SY; Szawka RE; Garlet GP; Teixeira MM; Silva TA
J Cell Biochem; 2018 Nov; 119(10):8511-8521. PubMed ID: 30011081
[TBL] [Abstract][Full Text] [Related]
11. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
12. Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.
Zhu G; Chen W; Tang CY; McVicar A; Edwards D; Wang J; McConnell M; Yang S; Li Y; Chang Z; Li YP
Int J Biol Sci; 2022; 18(14):5522-5538. PubMed ID: 36147479
[TBL] [Abstract][Full Text] [Related]
13. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
[TBL] [Abstract][Full Text] [Related]
16. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
17. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.
Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B
Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis.
Zheng XF; Zhao ED; He JY; Zhang YH; Jiang SD; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):112-121. PubMed ID: 27237582
[TBL] [Abstract][Full Text] [Related]
19. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
20. Fas receptor is required for estrogen deficiency-induced bone loss in mice.
Kovacic N; Grcevic D; Katavic V; Lukic IK; Grubisic V; Mihovilovic K; Cvija H; Croucher PI; Marusic A
Lab Invest; 2010 Mar; 90(3):402-13. PubMed ID: 20084056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
